Results 21 to 30 of about 53,894 (278)

Association of Types of Diabetic Macular Edema with Different Anti-Diabetic Therapies

open access: yesEndocrinology Research and Practice, 2020
Objective: To evaluate and assess the association of diabetic macular edema with different anti-diabetic therapy regimens. Material and Methods: We recruited 340 patients with prediagnosed Type 2 diabetes mellitus attending the ophthalmology and medicine
Luxmi SINGH   +3 more
doaj   +1 more source

Acute onset of fingolimod-associated macular edema

open access: yesAmerican Journal of Ophthalmology Case Reports, 2016
Purpose: Fingolimod is among the first oral disease-modifying agents for the treatment of relapsing-remitting multiple sclerosis (MS). Despite its favorable safety profile, fingolimod may cause macular edema, a significant adverse event, which occurs ...
Mohamed Kamel Soliman   +7 more
doaj   +1 more source

Novel rodent models for macular research [PDF]

open access: yes, 2010
BACKGROUND: Many disabling human retinal disorders involve the central retina, particularly the macula. However, the commonly used rodent models in research, mouse and rat, do not possess a macula.
Gesine Huber   +53 more
core   +1 more source

Corticosteroid Treatment in Diabetic Macular Edema [PDF]

open access: yes, 2017
Diabetic macular edema is the most common cause of visual impairment in patients with diabetes mellitus. The pathogenesis of macular edema is complex and multifactorial.
Burcu Nurözler Tabakcı, Nurten Ünlü
core   +1 more source

Correlation of inflammatory and proangiogenic cytokines from undiluted vitreous samples with spectral domain OCT scans, in untreated branch retinal vein occlusion [PDF]

open access: yes, 2013
Purpose: To assess the levels of inflammatory and angiogenic cytokines in undiluted vitreous from treatment-naïve patients with macular edema secondary to nonischemic branch retinal vein occlusion (BRVO), with flow cytometric bead array (CBA) and to ...
Michaelis, Martin   +8 more
core   +1 more source

Macular Hole Progression after Intravitreal Bevacizumab for Hemicentral Retinal Vein Occlusion

open access: yesCase Reports in Ophthalmological Medicine, 2011
Macular edema secondary to retinal vein occlusion is commonly being treated with off-label intravitreal bevacizumab with good outcomes. A significant reduction in macular edema and improvement in visual acuity is seen following such a treatment with no ...
Manish Nagpal   +2 more
doaj   +1 more source

Atypical Refractory Macular Edema: Are We Missing Something?

open access: yesJournal of Ophthalmic & Vision Research, 2022
Purpose: To report a case of bilateral refractory macular edema in a diabetic macular edema in a diabetic with an underlying systemic illness. Case Report: A 65-year-old male presented with the symptom of blurred vision in both eyes for three months.
Chaitra Jayadev   +2 more
doaj   +1 more source

OCT Patterns of Macular Edema in Intermediate Uveitis

open access: yesOftalʹmologiâ
Objective. To evaluate characteristic OCT morphological characteristic of initial presentation and chronic recurrent macular edema (ME) in patients with intermediate uveitis.Materials and methods.
I. E. Panova, V. G. Gvazava
doaj   +1 more source

Risperidone-related bilateral cystoid macular edema: a case report

open access: yesJournal of Medical Case Reports, 2019
Background A report of the second known case of bilateral cystoid macular edema in a patient taking risperidone. Case presentation We report a case of a 69-year-old African American woman using risperidone who presented with worsening visual acuity and ...
Anna Kozlova   +2 more
doaj   +1 more source

A Prospective Study of Safety Profile and Efficacy of three doses of Intravitreal Bevacizumab in Diabetic Macular Edema

open access: yesIJRETINA (International Journal of Retina), 2021
Introduction: Current study aimed to evaluate efficacy of intravitreal Bevacizumab in Diabetic macular edema, and to identify their ocular and systemic complications if any.
Nasrin Y, Sharma Ajay, Sharmila Yalakala
doaj   +1 more source

Home - About - Disclaimer - Privacy